OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
R2R01: A long‐acting single‐chain peptide agonist of RXFP1 for renal and cardiovascular diseases
Bruno Poirier, Olivier Pasquier, Xavier Chénedé, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 13, pp. 1993-2011
Closed Access | Times Cited: 7
Bruno Poirier, Olivier Pasquier, Xavier Chénedé, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 13, pp. 1993-2011
Closed Access | Times Cited: 7
Showing 7 citing articles:
An Introduction to the Special Issue “9th International Conference on Relaxin and Related Peptides”
Robert G. Bennett, Sabine Hombach‐Klonisch, Thomas Klonisch, et al.
Biochemical Pharmacology (2025), pp. 116775-116775
Closed Access
Robert G. Bennett, Sabine Hombach‐Klonisch, Thomas Klonisch, et al.
Biochemical Pharmacology (2025), pp. 116775-116775
Closed Access
Identification of key genes and signaling pathway in the pathogenesis of Huntington's disease via bioinformatics and next generation sequencing data analysis
Basavaraj Vastrad, Chanabasayya Vastrad
Egyptian Journal of Medical Human Genetics (2025) Vol. 26, Iss. 1
Open Access
Basavaraj Vastrad, Chanabasayya Vastrad
Egyptian Journal of Medical Human Genetics (2025) Vol. 26, Iss. 1
Open Access
Optimization of Single Relaxin B-Chain Peptide Leads to the Identification of R2R01, a Potent, Long-Acting RXFP1 Agonist for Cardiovascular and Renal Diseases
Sergio Mallart, Raffaele Ingenito, Paola Magotti, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Sergio Mallart, Raffaele Ingenito, Paola Magotti, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Engineering a long acting, non-biased relaxin agonist using Protein-in-Protein technology
Irina U. Agoulnik, Elena M Kaftanovskaya, Courtney Myhr, et al.
Biochemical Pharmacology (2024) Vol. 227, pp. 116401-116401
Closed Access | Times Cited: 3
Irina U. Agoulnik, Elena M Kaftanovskaya, Courtney Myhr, et al.
Biochemical Pharmacology (2024) Vol. 227, pp. 116401-116401
Closed Access | Times Cited: 3
Engineering and Characterization of a Long-Half-Life Relaxin Receptor RXFP1 Agonist
Sarah C. Erlandson, Jialu Wang, Haoran Jiang, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 9, pp. 4441-4449
Open Access | Times Cited: 3
Sarah C. Erlandson, Jialu Wang, Haoran Jiang, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 9, pp. 4441-4449
Open Access | Times Cited: 3
Therapeutic potential of relaxin or relaxin mimetics in managing cardiovascular complications of diabetes
Arun George Devasia, Meyammai Shanmugham, Adaikalavan Ramasamy, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116507-116507
Closed Access | Times Cited: 2
Arun George Devasia, Meyammai Shanmugham, Adaikalavan Ramasamy, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116507-116507
Closed Access | Times Cited: 2
Sex differences in relaxin responses in adults and with aging
Giannie Barsha, Kate M. Denton
Elsevier eBooks (2024), pp. 135-160
Closed Access
Giannie Barsha, Kate M. Denton
Elsevier eBooks (2024), pp. 135-160
Closed Access
